We do not have a Nominating Committee. Rather our entire Board of Directors performs the services ordinarily undertaken by the Nominating Committee
. Our Board, which currently consists of Chaim Lieberman
, has approved the nomination of Chaim Lieberman, Jeremy Werblowsky and Meir Silver.
, age 47, founded, and acted as the first CEO of Amazon Biotech, Inc.
(a private company which merged into the present company) in 2003 and has since conducted new business development and new drug development for Amazon.
In 2004, Mr. Lieberman
also founded, and has since conducted new business development for, Mazal Plant Pharmaceuticals, Inc.
On July 30, 2010, Amazon Biotech filed an action against Chaim Lieberman
and Eliyahu Bental Tolchinsky. The lawsuit was initiated by Dr. Mechael Kanovsky and Mr. Simcha Edell, former officers and directors of the Company. (United States District Court for the District of Utah Civil Action No. 2:10-cv-00712-CW).
Chaim Lieberman is Amazon's sole officer and director.